![Pierre Kyme](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 36 446 $ al 31/05/2026
Pierre Kyme currently works at Special Phage Services Pty Ltd., as Director, Special Phage Holdings Pty Ltd., as Director, AmpliPhi Australia Pty Ltd., as Director, C3J Therapeutics, Inc., as Director-Product Development from 2012, and Armata Pharmaceuticals, Inc., as Chief Business Officer from 2024.
Dr. Kyme received his doctorate degree from The University of Sydney.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 17/04/2026 | 4.461 ( 0,01 % ) | 36 446 $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ARMATA PHARMACEUTICALS, INC. | Public Communications Contact | - |
C3J Therapeutics, Inc.
 C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Corporate Officer/Principal | 01/01/2012 |
AmpliPhi Australia Pty Ltd.
 AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Director/Miembro de la Junta | - |
Special Phage Holdings Pty Ltd.
 Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Director/Miembro de la Junta | - |
Special Phage Services Pty Ltd.
 Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Director/Miembro de la Junta | - |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 6 |
|---|---|
The University of Sydney
 The University of Sydney Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Special Phage Services Pty Ltd.
Special Phage Services Pty Ltd. Medical SpecialtiesHealth Technology Develops bacteriophage therapy services | Health Technology |
Special Phage Holdings Pty Ltd.
Special Phage Holdings Pty Ltd. Medical SpecialtiesHealth Technology Operates as a holding company with interests in phage therapy | Health Technology |
AmpliPhi Australia Pty Ltd.
AmpliPhi Australia Pty Ltd. Medical SpecialtiesHealth Technology Develops gene therapy products | Health Technology |
C3J Therapeutics, Inc.
C3J Therapeutics, Inc. BiotechnologyHealth Technology Engages in discovery and development of novel targeted antimicrobials-synthetic bacteriophage & antimicrobial peptides | Health Technology |
Armata Pharmaceuticals, Inc.
 Armata Pharmaceuticals, Inc. BiotechnologyHealth Technology Operates as a biotechnology company focused on the development and commercialization of novel targeted antimicrobials | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
